lecanemab

Studying the Genes That Delay Alzheimer’s Decline May Lead to Treatments

New Alzheimer’s Drugs Don’t Deserve the Hype – Here’s Why

Amyloidosis: Beyond Alzheimer’s and Parkinson’s

As US FDA Approves New Drug for Alzheimer’s, Scientists Flag Safety Concerns